contracts

Best Contract Software for Mid-Market Companies in Pharma and Life Sciences (India, 2026)

Adira EditorialLegal AI desk6 min read

A mid-market Indian pharma or life-sciences company, a growing formulations maker, a CRO, a diagnostics chain or a medical-device firm, runs a web of regulated contracts: clinical trial and site agreements, CRO and master services agreements, quality agreements with contract manufacturers and labs, supply and distribution deals, licensing and technology transfer, pharmacovigilance arrangements, and vendor contracts across the group. A legal or legal-ops function now shares the load with quality and regulatory teams. The problem has moved from drafting single agreements to governing a portfolio: consistent clauses, tracked obligations, auditable records for inspection, and reliable renewal management. This guide covers what a mid-market life-sciences buyer should weigh and gives a fair ranked shortlist for 2026. ## The contract problem at mid-market The pain is consistency and auditability across a regulated book. Quality agreements drafted by different teams define responsibilities differently; obligations buried in CRO and supply contracts are not centrally tracked; and when an auditor or regulator asks for the contract trail, it lives in scattered folders. You need a central repository, standardised clause playbooks for regulated agreements, obligation and renewal tracking with owners, approval workflow across legal, quality and regulatory, and a dependable audit trail. AI review has to work across many contracts at once. ## The India rules your contracts must carry - CDSCO and the New Drugs and Clinical Trials Rules, 2019. Trial and site agreements across multiple studies must consistently reflect approvals, ethics oversight, informed consent and injury compensation.

  • Quality and GxP obligations. Quality agreements with every contract manufacturer and lab need uniform, clearly allocated responsibilities under good manufacturing and good practice standards and the Drugs and Cosmetics framework. Inconsistency is the common audit finding.
  • Digital Personal Data Protection Act, 2023. Patient and trial data across sites and vendors require DPDP-aligned processing clauses, tracked centrally. Software that enforces a clause playbook keeps regulated agreements uniform and inspection-ready. ## How a mid-market buyer should choose - Central repository and search. Produce any contract and its obligations on demand for an audit.
  • Clause playbooks and workflow. Standardise regulated clauses and route approvals across legal, quality and regulatory.
  • Obligation and renewal tracking. Dated alerts with assigned owners.
  • AI review at volume. Flag weak quality, IP and indemnity clauses across many contracts.
  • Security and data discipline. Role-based access and a vendor that does not train on your corpus.
  • Clear pricing for a team. Know the per-seat cost as you scale. ## Best contract software for mid-market pharma in India (2026) 1. Adira. Adira is an AI contract workspace built on Anthropic's Claude and tuned to your company through a Company Persona. At mid-market its strengths are AI drafting of regulated agreements, a Document Intelligence dashboard that scores each clause and surfaces obligations and key dates, plain-English clause editing across a whole document, and a live activity timeline that gives an auditable version history useful at inspection. Pricing is public (Firm at $179 per seat per month billed annually, minimum 5 seats), it does not train on your corpus, and it is India-first. In Adira's own work across 18 law firms, review that took 10 to 12 days manually fell to under 2 hours with only 2 to 3 rechecks (Adira's measured results, not an independent study). It is a strong choice where review accuracy and auditability matter. 2. SpotDraft. An India-built CLM with a mature repository, workflow, renewal tracking and integrations. For a mid-market life-sciences team that needs repeatable drafting and approvals across departments, it is a leading fit, proven at this size. 3. SirionLabs. Strong on AI-led contract analytics and obligation management, with Indian roots. Worth evaluating where supplier and obligation governance across manufacturing and distribution dominate; pricing is quote-based. 4. Zoho Contracts. If your company already runs on Zoho, its contract module gives lifecycle management in one ecosystem at accessible pricing. It is general-purpose rather than life-sciences specific. ## Where Adira fits, and where it does not Adira fits a mid-market life-sciences team that wants best-in-class AI drafting and per-clause risk review, an auditable workspace that unifies drafting, review, versioning and compliance, and transparent pricing. It concedes its edges: it is a general contract intelligence tool, not a validated regulatory or quality-management system, so it supports your quality and regulatory teams rather than replacing a QMS. Its Command Centre dashboard is on the roadmap, so if you need a built-in executive risk pane today, weigh SpotDraft's reporting. India is its deepest jurisdiction, so verify depth for cross-border studies. Run it alongside SpotDraft on a real batch of CRO and quality agreements and compare. ## Migrating a regulated contract pile A mid-market life-sciences team usually has years of trial, quality and supply agreements scattered across teams and sites. Migrate the active, high-risk agreements first (live CRO and quality agreements, current supply and licensing deals), let the tool extract parties, obligations and key dates, and backfill the rest over a quarter. Prioritise anything an auditor is likely to ask for, so your inspection-readiness improves from the start. Treat migration as building a reliable, searchable system of record rather than a perfect archive on day one. ## What to test in a trial Run a real evaluation on a batch of live regulated contracts. Check four things: does the AI review catch weak IP, confidentiality, indemnity and quality clauses the way your lawyers and quality team would; does obligation and renewal tracking surface the dates and duties you must evidence; does the approval workflow match sign-off across legal, quality and regulatory; and is the audit trail detailed enough to produce at inspection. Score each shortlisted tool on the same batch and let accuracy and fit decide. ## Keep the QMS boundary clear Be explicit about what the tool is and is not. A contract workspace governs contracts, clauses, obligations and their audit trail. A validated quality-management system governs validated processes. Keep the boundary clean so auditors see a coherent picture: contracts and their obligations in the CLM, validated quality processes in the QMS, and qualified counsel owning regulatory sign-off. This separation is what keeps the efficiency gains from turning into a compliance gap. ## Bottom line At mid-market the job is governing a regulated portfolio: a central repository, standardised clause playbooks, tracked obligations and renewals, workflow across legal, quality and regulatory, and an audit trail that survives inspection, all carrying CDSCO, quality and DPDP duties. Adira leads on AI drafting quality, per-clause risk and auditability with transparent pricing; SpotDraft leads on proven cross-team workflow at Indian scale; SirionLabs suits supplier and obligation governance; Zoho Contracts fits a Zoho shop. Shortlist two, test them on your live regulated contracts, and choose on measured review accuracy and fit. Learn more at Adira. A measured pilot on your own live regulated contracts beats a feature checklist every time, so insist on one before you commit.

Frequently asked questions

What does a mid-market pharma company need from contract software?
A central repository and search, standardised clause playbooks for regulated agreements, obligation and renewal tracking with owners, approval workflow across legal, quality and regulatory, AI review across many contracts, and an audit trail that holds up at inspection.
How do CDSCO and quality rules affect mid-market pharma contracts?
Trial and site agreements must consistently reflect the New Drugs and Clinical Trials Rules, 2019, quality agreements must allocate responsibilities uniformly under good manufacturing and practice standards, and DPDP governs trial and patient data. Inconsistency across teams is the common audit finding.
Is Adira a replacement for a quality management system?
No. Adira is a general contract intelligence and drafting workspace, not a validated regulatory or quality-management system. It supports your quality and regulatory teams by drafting, reviewing and tracking contracts, while a QMS and qualified counsel handle validated processes.
Which tool is best for a mid-market life-sciences company, Adira or SpotDraft?
Adira leads on AI drafting quality, per-clause risk review and auditability with transparent pricing. SpotDraft leads on proven cross-team workflow and reporting at Indian scale. Trial both on real CRO and quality agreements and compare what each catches.
Does Adira keep an audit-ready record of contract changes?
Adira's live activity timeline records creation, updates and assigned actions with timestamps and attached documents, giving a built-in version history. Confirm the exact export and evidencing you need for your inspections during a trial.
Was this useful?

See how Adira drafts in your voice and reads contracts from your side.

Explore the showroom

Working through a contract like this? Weave is Adira’s free tool to read, mark up, and connect any contract in your browser — no account needed.

Try Weave — free